The FDA discards its outside experts, which it never does, to approve the first new Alzheimer's drug in 18 years, after Biogen flexes celebrities and marketing.
Biogen warps the FDA on Alzheimer's drug
Biogen warps the FDA on Alzheimer's drug
Biogen warps the FDA on Alzheimer's drug
The FDA discards its outside experts, which it never does, to approve the first new Alzheimer's drug in 18 years, after Biogen flexes celebrities and marketing.